Antifouling and pH-Responsive Poly(Carboxybetaine)-Based Nanoparticles for Tumor Cell Targeting
Author(s) -
Feng Ding,
Shuang Yang,
Zhiliang Gao,
Jianman Guo,
Peiyu Zhang,
Xiaoyong Qiu,
Qiang Li,
Mingdong Dong,
Jingcheng Hao,
Qun Yu,
Jiwei Cui
Publication year - 2019
Publication title -
frontiers in chemistry
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.027
H-Index - 52
ISSN - 2296-2646
DOI - 10.3389/fchem.2019.00770
Subject(s) - methacrylate , ethylene glycol , surface modification , nanoparticle , polymer , hela , peg ratio , chemistry , nanocarriers , biofouling , drug delivery , combinatorial chemistry , polymer chemistry , biophysics , materials science , nanotechnology , organic chemistry , membrane , biochemistry , cell , polymerization , finance , economics , biology
Nanocarriers with responsibility and surface functionality of targeting molecules have been widely used to improve therapeutic efficiency. Hence, we report the assembly of pH-responsive and targeted polymer nanoparticles (NPs) composed of poly(2-(diisopropylamino)ethyl methacrylate) (PDPA) as the core and poly(carboxybetaine methacrylate) (PCBMA) as the shell, functionalized with cyclic peptides containing Arginine-Glycine-Aspartic acid- D -Phenylalanine-Lysine (RGD). The resulting polymer NPs (PDPA@PCBMA-RGD NPs) can maintain the pH-responsivity of PDPA (pKa ~6.5) and low-fouling property of PCBMA that significantly resist non-specific interactions with RAW 264.7 and HeLa cells. Meanwhile, PDPA@PCBMA-RGD NPs could specifically target α v β 3 integrin-expressed human glioblastoma (U87) cells. The pH-responsiveness and low-fouling properties of PDPA@PCBMA NPs are comparable to PDPA@poly(ethylene glycol) (PDPA@PEG) NPs, which indicates that PCBMA is an alternative to PEG for low-fouling coatings. The advantage of PDPA@PCBMA NPs lies in the presence of carboxyl groups on their surfaces for further modification (e.g., RGD functionalization for cell targeting). The reported polymer NPs represent a new carrier that have the potential for targeted therapeutic delivery.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom